We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies. Close

Rise of pharmaceutical nationalism?

Intellectual Property Magazine

Rise of pharmaceutical nationalism?

Queen Mary Intellectual Property Research Institute’s Duncan Matthews asks whether the US stance on tackling Covid-19 is enlightened independence or the sign of a new protectionist era?

The recent announcement that the US will leave the World Health Organization (WHO)  was presaged by news that the country had disassociated itself from key provisions in the World Health Assembly Covid-19 Response Resolution that refer to intellectual property rights. Yet, both announcements belie a pharmaceutical industry reliant on global supply chains and a symbiotic relationship between the US and China.

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, please enter your details below to log in.

Enter your email address to log in as a user on your corporate account.
Remember me on this computer

Not yet an i-law subscriber?


Request a trial Find out more